AUSSENWIRTSCHAFT AUSTRIA

International Health Day 2026

24–25 Mar 2026 | Vienna, Austria

HomeAgendaSpeakerMarketplaceContactEEN Support Offices
Register
Register
Register

ProductUpdated on 17 February 2026

Zilia Ocular

Dario Zujo

Business Development Director at Zilia

Québec, Canada

About

Zilia Ocular is a next-generation retinal imaging and spectroscopy platform designed to measure metabolic biomarkers in the tissues of the eye fundus—starting with oxygen saturation (StO₂). By combining advanced imaging, multi-wavelength spectroscopy, and intelligent software, it provides real-time, quantitative insights into ocular metabolism.

Unlike traditional technologies that detect structural damage once it has already occurred, Zilia Ocular captures functional and metabolic changes that often precede irreversible tissue loss. Because oxygen dysregulation plays a key role in diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration, measuring retinal oxygenation enables earlier detection, improved risk assessment, and more personalized treatment monitoring.

As the first retinal camera designed to assess oxygen saturation directly in eye tissue—not just large blood vessels—Zilia Ocular opens the door to a new era of precision diagnostics in ophthalmology, while also expanding opportunities in neurology, cardiology, and pharmaceutical research.

Looking for

  • Distribution Partner
  • Clinical Partner

Applies to

  • Medical Devices
  • Diagnostics

Organisation

Zilia

Medtech company

Quebec, Canada

Similar opportunities